Pattern as an Incidental Finding Require Further Assessment? The asymptomatic patient found to have the Wolff-Parkinson-White (WPW) pattern as an incidental observation poses a difficult management dilemma. On one hand, the occurrence of sudden death as the initial manifestation of the WPW syndrome is extremely rare1-4 and argues for a noninterventional approach. On the other hand, the infrequent but well-known occurrence of sudden death5,6 argues for some attempt to prognosticate when the issue is raised.
Point of View
Pattern as an Incidental Finding Require Further Assessment? The asymptomatic patient found to have the Wolff-Parkinson-White (WPW) pattern as an incidental observation poses a difficult management dilemma. On one hand, the occurrence of sudden death as the initial manifestation of the WPW syndrome is extremely rare1-4 and argues for a noninterventional approach. On the other hand, the infrequent but well-known occurrence of sudden death5,6 argues for some attempt to prognosticate when the issue is raised.
Individuals with WPW resuscitated from ventricular fibrillation as a consequence of WPW-related arrhythmia5 are invariably found to have atrial fibrillation with a very rapid ventricular response (minimum preexcited RR interval, <250 msec) at a baseline electrophysiology study. The majority have a history of reciprocating atrioventricular tachycardia, and many have multiple accessory pathways. Approximately 12% are entirely asymptomatic before cardiac arrest, and a further 20% have relatively minor symptoms. It is reasonable to conclude that the finding of a minimum preexcited RR interval of 250 msec or less is a sensitive "marker" identifying the patient destined to have sudden cardiac death, although use of this marker in an asymptomatic patient is associated with serious obstacles. In one study, 17% of asymptomatic patients with the WPW pattern were found to have a shortest RR of less than 250 msec. 4 Consequently, the absence of this finding might be useful for its negative predictive value, but the number of people Smith,3 none per 240 patient years) and suggests a sudden death rate in the order of one per 1,000 patient years of follow-up. The positive predictive value of a minimum preexcited RR interval less than 250 msec in these circumstances will obviously be quite low. Review of the literature on cardiac pathology in sudden cardiac death victims in general7 demonstrates that the great majority of such patients have structural heart disease; this argues against a high incidence of sudden death in patients with undiagnosed WPW, the great majority of whom have no structural heart disease. Because of the low risk of death in patients with asymptomatic WPW, the use of this marker (shortest RR interval, <250 msec) in clinical practice may not yield as much useful information as once believed. The reasons for this are illustrated in Table 1 . The patient population described in this table is a group of 10,000 patients with asymptomatic WPW followed for 10 years. The following assumptions have been made: the risk of sudden death in this untreated population is 0.1% per patient year,1-4 approximately 17% of asymptomatic WPW patients will have a shortest RR interval of 250 msec or less on electrophysiologic testing,4 and the sensitivity of this test in predicting sudden death is 95% (i.e., 95% of patients who die suddenly have a shortest RR interval of .250 msec).5 With this information, the numbers displayed in Table 1 can be calculated. 8 It can be seen that although the sensitivity and specificity of the test are reasonably high (95% and 84%, respectively), the positive predictive value is low. Of patients who have a shortest RR interval of 250 msec or less, only 5.6% will suffer sudden death during 10 years of follow-up. Before using the test, the pretest likelihood of sudden death in the population of WPW patients as a whole was 1% (0.1% per year for 10 years). Thus, a positive test has increased the likelihood of sudden death from 1% to 100 9,900 10,000 SRR, shortest preexcited interval during atrial fibrillation; FN, false-negative; FP, false-positive; TN, true-negative; TP, truepositive.
Sensitivity, TP/(TP+FN) (95%); specificity, TN/(TN+FP) (84%); positive predictive value, TP/(TP+FP) (5.6%); negative predictive value, TN/(FN+TN) (99.9%).
5.6%
. Although the likelihood that the patient will die if the test is negative is virtually zero, the pretest likelihood of dying was only 1%.
Thus, in patients with asymptomatic WPW, the clinical value of using a shortest RR interval of 250 msec or less as a predictor of patients at high risk of sudden death is negligible if the test is negative and small if it is positive. The clinical importance of the additional information provided by a positive test may be greater in individual patients depending on specific considerations. One can manipulate the marker of a shortest RR interval of less than 250 msec as desired. Of course, lowering the cutoff value improves specificity at the expense of sensitivity. The fact that the event rate is too low to allow a marker of even excellent sensitivity and specificity to have a good positive predictive value still cannot be evaded.
Are Noninvasive Tests Helpful in Assessing the Risk of Sudden Death? Clinical criteria and noninvasive tests have been advocated to predict the presence or absence of a minimal preexcited RR interval of 250 msec or less during atrial fibrillation induced in the control state. The occurrence of intermittent block in the accessory pathway in the course of monitoring or serial electrocardiographic examinations intuitively suggests a low margin of safety for conduction over the accessory pathway and, consequently, a slower preexcited ventricular response in the event of atrial fibrillation. The same principle applies to sudden loss of accessory pathway conduction during exercise testing occurring at a critical heart rate. Recent data substantiate "intermittent" accessory pathway conduction as a reliable predictor of a slower ventricular response (minimum preexcited RR interval, >250 msec) during atrial fibrillation. 9 Wellens and coworkers10 11 suggested that loss of preexcitation after intravenous administration of a class I antiarrhythmic drug occurs, in general, only with accessory pathway with longer (>270 msec) anterograde refractory periods of the accessory pathways, and evidence supporting this viewpoint has been presented with several class 1 antiarrhythmic drugs. [0] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] This concept was challenged by Fananapazir and colleagues,13 who found that loss of preexcitation after intravenous procainamide was neither sensitive nor specific for predicting preexcited RR interval of less than 250 msec during atrial fibrillation. Boahene et al14 studied the effects of incremental doses of intravenous procainamide and showed that prediction of minimum preexcited RR interval of less than 250 msec was related to the dose of procainamide. In this preliminary report, specificity was excellent at cumulative doses of less than 500 mg procainamide, but specificity was lost at higher dosages as used in the study of Fananapazir et al. This issue is unresolved and appears to depend on patient selection as well as dosage and infusion rate of the medication used.
Although electrocardiographic markers and pharmacologic tests may be useful in predicting minimum preexcited shortest RR interval of more than or less than 250 msec during atrial fibrillation, they clearly are not equivalent to the actual induction of atrial fibrillation, by either transvenous or esophageal techniques. Nonetheless, the management of the patient with a "positive" response (prediction of shortest RR interval of less than 250 msec) is subject to the same difficulties as the actual determination of minimum RR during atrial fibrillation.
Will a Large Prospective Natural History Study of
Asymptomatic WPW Pattern Clarify the Dilemma?
Authors addressing the issue of asymptomatic WPW pattern frequently include a plea's for a large, prospective natural history study of the asymptomatic individual to resolve our current dilemma. Preliminary data from such a study have been presented.4 When the study was begun in 1979, the hypothesis was that the individual at risk could be identified by virtue of a minimum preexcited RR interval during induced atrial fibrillation of less than 250 msec and ultimately could be targeted for an appropriate intervention. The observation that 17% of patients have a shortest RR interval of less than 250 msec at electrophysiologic study made it clear that this was a nonspecific marker of sudden death. The low sudden death rate in this study4 to this point (no sudden deaths for more than 350 patient years of follow-up) verified the low event rate of other studies. Difficult moral issues were also encountered in dealing with patients thought to be at potential risk by the investigators even though this risk has not been rigidly established by a prospective study. Concerns were raised over "labeling" an asymptomatic patient as potentially high risk and creating psychologic problems. At this point, we are fully aware that the finding of a rapid ventricular response during induced atrial fibrillation has poor positive predictive value for sudden death and the event rate, although not exactly known, is very low and probably in the order of one per 1,000 or more patient years of follow-up. These issues raise formidable problems for any large-scale prospective natural history study. Indeed, the additional data gained from a large natural history study at this stage, even if logistically possible, may not help in the management of the asymptomatic patient. The fundamental problem remains in the merit of intervening with associated cost and complications in a patient whose risk of sudden cardiac death is very ",low."
A compelling argument can be made on epidemiologic grounds for nonintervention in the asymptomatic patient found to have the WPW pattern. Realistically, however, the physician confronted with a patient still faces a difficult situation. This patient must be told that the risk of sudden arrhythmic death is extremely low but, nonetheless, still present. Medicolegal issues also come into play in a complex fashion. Here, the "aggressive" physician faces the problem of a potential complication during investigation and treatment of an asymptomatic patient with a very low risk of sudden death, whereas the "conservative" physician faces the implications of nonintervention in a patient who may subsequently have an event! The issue becomes still more complicated if the patient is in a visible occupation such as aviation, professional athletics, or operation of heavy industrial equipment.
Suggested Guidelines
It is our view that mass screening and aggressive investigation of asymptomatic patients with WPW pattern is not justified by epidemiologic data. However, the patient who comes to medical attention because of an incidental finding of WPW pattern should be informed of the probable and possible outcomes. The decision to investigate further can then be made by mutual agreement between the patient and physician on an individual basis. It is obvious that current data do not allow a firm recommendation one way or another and that the patient and individual considerations must play a major role in this decision.
Assuming that the patient elects to have further investigation, the following risk stratification based on induced atrial fibrillation5,6 is suggested: category 1, shortest preexcited RR interval less than 220 msec-definite risk; category 2, shortest preexcited RR interval less than 250 and more than 220 msecprobable risk; category 3, shortest preexcited RR interval less than 300 and more than 250 msecpossible risk; and category 4, shortest preexcited RR interval more than 300 msec-negligible risk.
Patients with shortest RR interval of less than 220 msec were selected as the highest risk group because the great majority of sudden death survivors are found to have shortest RR interval of less than 220 msec.5,6 Fewer survivors have shortest RR interval between 220 and 250 msec (category 2), and shortest RR interval between 250 and 300 msec in survivors of ventricular fibrillation is rarely reported.12 The presence of inducible reciprocating tachycardia, multiple accessory pathways, or average shortest RR interval of 360 msec or less probably enhances the risk of an event in risk categories 1 and 2.5,6,16 It is important not to confuse definite risk with high risk.
Definite risk is when a patient is clearly in the risk category, even if that risk is relatively low. The results of testing can be discussed with the patient, and a decision regarding further therapy can be made. All patients should be educated about the potential symptoms of tachycardia with the main goal being to alert the patient to seek prompt medical attention with the onset of symptoms. In general, this should suffice for patients in risk categories 3 and 4. Accepting that the benefit of prophylactic drug therapy has not been demonstrated and that this has been discussed with the patient, we believe that medical prophylaxis may be offered for risk category 1, and possibly category 2, with the goal of increasing the shortest preexcited RR interval to more than 250 msec. Rarely, surgical intervention may be considered appropriate under specialized circumstances such as when the patient's career or livelihood is prevented by even a small potential for serious arrhythmia. Repeat electrophysiologic assessment (by transvenous or esophageal techniques) may be offered periodically over the years in risk categories 1 and 2 as current data suggest that the risk of a rapid ventricular response during atrial fibrillation may diminish with time. [17] [18] [19] [20] In general, isoproterenol testing is not helpful because the above guidelines are based on the results of studies done in the control state and also because isoproterenol in sufficient dosage would elevate the majority of individuals to risk categories 1 or 2, rendering stratification useless. 21 These guidelines are presented with the goal of providing direction to practioners based on our understanding of current data. It is hoped that they will serve as a starting point for further modification based on new data and consensus.
